Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
FMP010
/
GSK, Walter Reed Army Institute of Research
Welcome,
Profile
Billing
Logout
5 Diseases
0 Trials
0 Trials
5 News
||||||||||
FMP010
/
GSK, Walter Reed Army Institute of Research
Phase classification:
Evaluate the Safety and Efficacy of Plasmodium Falciparum Malaria Protein 010 (FMP010) Administered With Adjuvant AS01B
(clinicaltrials.gov) - Jun 9, 2020
P1b
, N=30, Completed,
Sponsor: U.S. Army Medical Research and Development Command
Phase classification: P1 --> P1b
||||||||||
FMP010
/
GSK, Walter Reed Army Institute of Research
Enrollment change:
A Study to Determine the Effects of an Investigational Malaria Vaccine Given to Adults Living in the United States and Thereafter to Adults Living in Kenya
(clinicaltrials.gov) - May 29, 2015
P1
, N=26, Completed,
Sponsor: U.S. Army Medical Research and Materiel Command
Phase classification: P1 --> P1b N=56 --> 26
|
|||||||||
FMP010
/
GSK, Walter Reed Army Institute of Research
New P1 trial:
Evaluate the Safety and Efficacy of Plasmodium Falciparum Malaria Protein 010 (FMP010) Administered With Adjuvant AS01B
(clinicaltrials.gov) - May 29, 2015
P1
, N=30, Completed,
Sponsor: U.S. Army Medical Research and Materiel Command
||||||||||
FMP010
/
GSK, Walter Reed Army Institute of Research
Enrollment change:
A Study to Determine the Effects of an Investigational Malaria Vaccine Given to Adults Living in the United States and Thereafter to Adults Living in Kenya
(clinicaltrials.gov) - Mar 15, 2012
P1
, N=56, Completed,
Sponsor: U.S. Army Medical Research and Materiel Command
N=56 --> 26 N=26 --> 56